These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 30983433)

  • 1. Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma.
    Lucarelli G; Loizzo D; Franzin R; Battaglia S; Ferro M; Cantiello F; Castellano G; Bettocchi C; Ditonno P; Battaglia M
    Expert Rev Mol Diagn; 2019 May; 19(5):397-407. PubMed ID: 30983433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics and Metabolic Reprogramming in Kidney Cancer.
    Weiss RH
    Semin Nephrol; 2018 Mar; 38(2):175-182. PubMed ID: 29602399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming in clear cell renal cell carcinoma.
    Wettersten HI; Aboud OA; Lara PN; Weiss RH
    Nat Rev Nephrol; 2017 Jul; 13(7):410-419. PubMed ID: 28480903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics informs common patterns of molecular dysfunction across histologies of renal cell carcinoma.
    DiNatale RG; Sanchez A; Hakimi AA; Reznik E
    Urol Oncol; 2020 Oct; 38(10):755-762. PubMed ID: 31155438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.
    Koch E; Finne K; Eikrem Ø; Landolt L; Beisland C; Leh S; Delaleu N; Granly M; Vikse BE; Osman T; Scherer A; Marti HP
    Am J Physiol Renal Physiol; 2019 May; 316(5):F1053-F1067. PubMed ID: 30838877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma.
    Lucarelli G; Rutigliano M; Sallustio F; Ribatti D; Giglio A; Lepore Signorile M; Grossi V; Sanese P; Napoli A; Maiorano E; Bianchi C; Perego RA; Ferro M; Ranieri E; Serino G; Bell LN; Ditonno P; Simone C; Battaglia M
    Aging (Albany NY); 2018 Dec; 10(12):3957-3985. PubMed ID: 30538212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies.
    Qi Y; Wang L; Wang K; Peng Z; Ma Y; Zheng Z; Shang D; Xu W; Zheng J
    Biomed Pharmacother; 2019 Mar; 111():821-834. PubMed ID: 30616081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Components of the RCC Grade.
    Ishimaru T
    Semin Nephrol; 2020 Jan; 40(1):14-27. PubMed ID: 32130962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics Analysis of Renal Cell Line Caki-2 with AFMID Overexpression and Potential Biomarker Discovery in Urine.
    Sun J; Chang J; Guo Z; Sun H; Xu J; Liu X; Sun W
    J Proteome Res; 2024 Oct; 23(10):4495-4507. PubMed ID: 39213636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SERPINH1 overexpression in clear cell renal cell carcinoma: association with poor clinical outcome and its potential as a novel prognostic marker.
    Qi Y; Zhang Y; Peng Z; Wang L; Wang K; Feng D; He J; Zheng J
    J Cell Mol Med; 2018 Feb; 22(2):1224-1235. PubMed ID: 29239102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma.
    Czyzyk-Krzeska MF; Landero Figueroa JA; Gulati S; Cunningham JT; Meller J; ShamsaeI B; Vemuri B; Plas DR
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33803184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma: a critical analysis of metabolomic biomarkers emerging from current model systems.
    Rodrigues D; Monteiro M; Jerónimo C; Henrique R; Belo L; Bastos ML; Guedes de Pinho P; Carvalho M
    Transl Res; 2017 Feb; 180():1-11. PubMed ID: 27546593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NDUFA4L2 expression predicts poor prognosis in clear cell renal cell carcinoma patients.
    Liu L; Lan G; Peng L; Xie X; Peng F; Yu S; Wang Y; Tang X
    Ren Fail; 2016 Sep; 38(8):1199-205. PubMed ID: 27453328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma.
    Sun X; Zhang H; Luo L; Zhong K; Ma Y; Fan L; Fu D; Wan L
    Oncol Rep; 2016 Dec; 36(6):3131-3138. PubMed ID: 27748938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic reprogramming of clear cell renal cell carcinoma.
    Zhu H; Wang X; Lu S; Ou K
    Front Endocrinol (Lausanne); 2023; 14():1195500. PubMed ID: 37347113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint analysis.
    Yang H; Li W; Lv Y; Fan Q; Mao X; Long T; Xie L; Dong C; Yang R; Zhang H
    Gene; 2019 Dec; 720():144103. PubMed ID: 31491435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco smoking induces metabolic reprogramming of renal cell carcinoma.
    Reigle J; Secic D; Biesiada J; Wetzel C; Shamsaei B; Chu J; Zang Y; Zhang X; Talbot NJ; Bischoff ME; Zhang Y; Thakar CV; Gaitonde K; Sidana A; Bui H; Cunningham JT; Zhang Q; Schmidt LS; Linehan WM; Medvedovic M; Plas DR; Figueroa JAL; Meller J; Czyzyk-Krzeska MF
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 32970633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathway analysis of kidney cancer using proteomics and metabolic profiling.
    Perroud B; Lee J; Valkova N; Dhirapong A; Lin PY; Fiehn O; Kültz D; Weiss RH
    Mol Cancer; 2006 Nov; 5():64. PubMed ID: 17123452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets.
    di Meo NA; Lasorsa F; Rutigliano M; Loizzo D; Ferro M; Stella A; Bizzoca C; Vincenti L; Pandolfo SD; Autorino R; Crocetto F; Montanari E; Spilotros M; Battaglia M; Ditonno P; Lucarelli G
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.